Compare BELFB & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BELFB | QDEL |
|---|---|---|
| Founded | 1949 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.7B |
| IPO Year | N/A | N/A |
| Metric | BELFB | QDEL |
|---|---|---|
| Price | $153.36 | $27.36 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $153.75 | $39.33 |
| AVG Volume (30 Days) | 186.0K | ★ 1.8M |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | ★ 0.18% | N/A |
| EPS Growth | ★ 19.52 | N/A |
| EPS | ★ 5.17 | N/A |
| Revenue | $649,376,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | $26.78 | N/A |
| Revenue Next Year | $6.19 | $2.65 |
| P/E Ratio | $29.84 | ★ N/A |
| Revenue Growth | ★ 23.70 | N/A |
| 52 Week Low | $58.00 | $19.50 |
| 52 Week High | $167.04 | $49.45 |
| Indicator | BELFB | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 53.49 | 58.78 |
| Support Level | $133.71 | $20.31 |
| Resistance Level | $152.26 | $28.37 |
| Average True Range (ATR) | 8.42 | 1.41 |
| MACD | 0.05 | 0.86 |
| Stochastic Oscillator | 56.56 | 88.95 |
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.